Aptose Biosciences Inc. (APTO)
Aptose Biosciences Statistics
Share Statistics
Aptose Biosciences has 2.55M shares outstanding. The number of shares has increased by 3.36% in one year.
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | 3.36% |
| Shares Change (QoQ) | 9.12% |
| Owned by Institutions (%) | 0.11% |
| Shares Floating | 499.77K |
| Failed to Deliver (FTD) Shares | 1.54K |
| FTD / Avg. Volume | 0.67% |
Short Selling Information
The latest short interest is 1.31M, so 2.18% of the outstanding shares have been sold short.
| Short Interest | 1.31M |
| Short % of Shares Out | 2.18% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 0.07 |
Valuation Ratios
The PE ratio is -185.81 and the forward PE ratio is -0.09. Aptose Biosciences's PEG ratio is 1.87.
| PE Ratio | -185.81 |
| Forward PE | -0.09 |
| PS Ratio | 0 |
| Forward PS | 0.7 |
| PB Ratio | -1040.08 |
| P/FCF Ratio | -945020.96 |
| PEG Ratio | 1.87 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aptose Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of -0.14.
| Current Ratio | 2.14 |
| Quick Ratio | 2.14 |
| Debt / Equity | -0.14 |
| Debt / EBITDA | - |
| Debt / FCF | -124.2 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-726.57K |
| Employee Count | 35 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -96.01% in the last 52 weeks. The beta is 1.13, so Aptose Biosciences's price volatility has been higher than the market average.
| Beta | 1.13 |
| 52-Week Price Change | -96.01% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 10.58 |
| Relative Strength Index (RSI) | 26.12 |
| Average Volume (20 Days) | 230.84K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -25.43M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 6.15M in cash and 621K in debt, giving a net cash position of 5.53M.
| Cash & Cash Equivalents | 6.15M |
| Total Debt | 621K |
| Net Cash | 5.53M |
| Retained Earnings | -540.97M |
| Total Assets | 10.93M |
| Working Capital | 477K |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures -5K, giving a free cash flow of -5K.
| Operating Cash Flow | 0 |
| Capital Expenditures | -5K |
| Free Cash Flow | -5K |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APTO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for APTO is $93, which is 5338.6% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $93 |
| Price Target Difference | 5338.6% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Feb 26, 2025. It was a backward split with a ratio of 1:30.
| Last Split Date | Feb 26, 2025 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -79.85 |
| Piotroski F-Score | 1 |